These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 16700709

  • 1. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
    Yu WL, Cheng KC, Chi CJ, Chen HE, Chuang YC, Wu LT.
    Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL, Wang JT, Lauderdale TL, Chang SC.
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [Abstract] [Full Text] [Related]

  • 3. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U, Boonkerd N, Polwichai P, Dejsirilert S, Niumsup PR.
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [Abstract] [Full Text] [Related]

  • 4. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA, Wu LT, Cheng KC, Ko WC, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [Abstract] [Full Text] [Related]

  • 5. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae.
    Biendo M, Manoliu C, Laurans G, Castelain S, Canarelli B, Thomas D, Hamdad F, Rousseau F, Eb F.
    Res Microbiol; 2008 Feb; 159(9-10):590-4. PubMed ID: 18845248
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria.
    Nedjai S, Barguigua A, Djahmi N, Jamali L, Zerouali K, Dekhil M, Timinouni M.
    J Infect Dev Ctries; 2013 Nov 15; 7(11):804-11. PubMed ID: 24240037
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, Woo GJ, Lee K.
    Diagn Microbiol Infect Dis; 2005 Apr 15; 51(4):265-9. PubMed ID: 15808318
    [Abstract] [Full Text] [Related]

  • 10. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
    Jiang X, Ni Y, Jiang Y, Yuan F, Han L, Li M, Liu H, Yang L, Lu Y.
    J Clin Microbiol; 2005 Feb 15; 43(2):826-31. PubMed ID: 15695687
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2007 Nov 15; 51(11):4015-21. PubMed ID: 17724160
    [Abstract] [Full Text] [Related]

  • 13. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
    Yu WL, Chuang YC, Walther-Rasmussen J.
    J Microbiol Immunol Infect; 2006 Aug 15; 39(4):264-77. PubMed ID: 16926972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.
    Liu G, Ling BD, Zeng Y, Lin L, Xie YE, Lei J.
    Jpn J Infect Dis; 2008 Jul 15; 61(4):286-9. PubMed ID: 18653970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emergence of TEM, SHV, and CTX-M-extended spectrum β-lactamases and class 1 integron among Enterobacter cloacae isolates collected from hospitals of Tehran and Qazvin, Iran.
    Peymani A, Farivar TN, Sanikhani R, Javadi A, Najafipour R.
    Microb Drug Resist; 2014 Oct 15; 20(5):424-30. PubMed ID: 24684320
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
    Wu JJ, Ko WC, Tsai SH, Yan JJ.
    Antimicrob Agents Chemother; 2007 Apr 15; 51(4):1223-7. PubMed ID: 17242140
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, Sordillo E, Polsky B, Peleg AY, Bhussar MK, Doi Y.
    Int J Antimicrob Agents; 2011 Jan 15; 37(1):26-32. PubMed ID: 21075605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.